ams Innovation in Medical Sensing Technology Recognized With Three Elektra Award Nominations
March 03 2021 - 10:05AM
Dow Jones News
ams (SIX: AMS), a leading worldwide supplier of high performance
sensor solutions, announces that it is shortlisted for three
Elektra awards in recognition of recent breakthroughs made by the
company in medical sensing technology. Two ams optical sensors have
separately been shortlisted for the Award for Excellence in Product
Design (Medical), while the company's Advanced Optical Sensors
division is shortlisted in the Award for Design Team of the Year.
Used in point-of-care and wearable-device applications, they make
an important contribution to Covid-19 (SARS-CoV-2) pandemic control
and blood oxygen saturation monitoring. Winners of the UK's
prestigious Elektra awards (www.elektraawards.co.uk/), hosted by
Electronics Weekly, are due to be announced on 25 March.
Shortlist: Award for Excellence in Product Design (Medical),
Elektra Awards 2021
First, the AS7038RB vital sign sensor enables the creation of
wearable and disposable equipment to accurately and safely measure
blood oxygen saturation (SpO(2) ). The sensor can continuously
monitor SpO(2) on all skin types in wearable devices such as
earbuds and patches. The high optical performance of the AS7038RB
means that it can be used in medical-grade patient monitoring
products, such as the disposable patches used for SpO(2) and
electro-cardiogram (ECG) measurement in hospital emergency rooms
and remote patient monitoring.
Second, ams' innovation through the miniaturized and
cost-effective AS7341L spectral sensor technology is another game
changer for healthcare applications. Enabling rapid test devices to
detect colorimetric and fluorescence spectral information through a
tiny, yet powerful, optical sensor supports wide-spread testing for
Covid-19 (SARS-CoV-2) antigens and antibodies as well as flu, other
viruses or other target analytes with the potential for a global
health crisis at disposable cost levels.
Shortlist: Design Team of the Year Award, Elektra Awards
2021
Development of the technology for Covid-19 (SARS-CoV-2)
diagnostic test kits based on the AS7341L has brought ams' Advanced
Optical Sensors division its third shortlisted place, in the Award
for Design Team of the Year. With the division's Executive Vice
President and General Manager Jennifer Zhao at the helm, the global
team in Europe, North America and Asia is reimagining ams spectral
sensing technologies for use in devices which provide rapid testing
for Covid-19. The team is working with companies around the world
on solutions that will help detect the presence of both Covid-19
antigens and antibodies sooner and deliver results in as little as
15 minutes.
For instance, a partnership between ams and Senova, a
manufacturer of in vitro diagnostic medical devices, is creating a
disposable electronic lateral flow test for measuring antibodies
against the Covid-19 (SARS-CoV-2) virus. The device, using lateral
flow technology coupled with the AS7341L, enables a read-out that
is accurate, cost effective, quantitative, and provides an
objective result which requires no user interpretation.
For further information on ams health sensing technologies
including point-of-care diagnostics, medical imaging and vital
signs monitoring, our new video on the ams 15-minute rapid test for
Covid-19 (SARS-CoV-2), and a list of customer implementations using
the AS7341L, see: https://ams.com/medical-health.
View source version on businesswire.com:
https://www.businesswire.com/news/home/20210303005637/en/
CONTACT: Amy Flécher
VP Marketing Communications / ams AG
press@ams.com
https://ams.com
SOURCE: ams
Copyright Business Wire 2021
(END) Dow Jones Newswires
March 03, 2021 09:50 ET (14:50 GMT)
FTSE 100
Index Chart
From Mar 2024 to Apr 2024
FTSE 100
Index Chart
From Apr 2023 to Apr 2024